Morphine Sulfate Injection, USP, CII (Preservative and Antioxidant Free)

50 mg/mL

1,000 mg/20 mL

Single Dose Glass Fliptop Vial

Unit of Sale NDC: 00409-1896-20

Available
To set product alerts you must or register

Cap color: Gray

Wholesalers
Cardinal 5887823
Cencora 10284731
McKesson 2882967
Morris & Dickson 325431
Ordering information
Unit of Sale size 1 Carton of 1 Vial
Case size 25 X 1
Cases per tier 25
Cases per pallet 400
Unit of Sale dimensions 2.75 x 1.5 x 1.5
Unit of Sale weight 0.137
Unit of Sale per shipper 25
Shipper outer dimensions 8.0 x 7.75 x 3.0
Shipper weight 3.425
Allergy information
Non-DEHP
Latex information
Preservative free
Gluten free
Availability specifics
Additional information View

If Latex Information is present above, then natural rubber latex has not been used in the manufacturing of this device or drug container closure system.

If Preservative Free is present above, then this product does not contain ingredients identified as a preservative, as defined by the USP.

Cap color: Gray

Unit of Sale NDC:00409-1896-20

Morphine Sulfate Injection, USP, CII (Preservative and Antioxidant Free)

Unit of Use NDC:00409-1896-20

Morphine Sulfate Injection, USP, CII (Preservative and Antioxidant Free)

Additional family SKUs (8)

Related news

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 50 mg/10 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Changes for Camptosar® (Irinotecan Hydrochloride Injection, USP) 40 mg/2 mL (20 mg/mL) Single Dose Vial and Camptosar® (Irinotecan Hydrochloride Injection, USP) 100 mg/5 mL (20 mg/mL) Single Dose Vial

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 250 mg/50 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change DOXOrubicin Hydrochloride Injection, USP 50 mg/25 mL (2 mg/mL) Single Dose Vial

Product Updates

Product NDC and Pack Size Changes for Lidocaine HCl 1% 200 mg/20 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP Multiple Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for DOXOrubicin Hydrochloride Injection, USP, Multiple Presentations

Product Updates

Product NDC Change for Idamycin PFS® (idarubicin hydrochloride injection) 5 mg/5 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC and Pack Size Change for Sterile Empty Vial 10 mL Glass Bottle

Product Updates

Product NDC and Vial Presentation Change for DOXOrubicin Hydrochloride Injection, USP 200 mg/100 mL (2 mg/mL) Multiple Dose Vial

Product Updates

Product NDC and Vial Presentation Change for Camptosar® (Irinotecan Hydrochloride Injection, USP) 300 mg/15 mL (20 mg/mL) Single Dose Vial

Product Updates

NDC and Formulation Change for Levofloxacin in 5% Dextrose Injection Flexible Container Presentations

Product Updates

Pfizer Hospital NDC and Packaging Change: Precedex

Product Updates

Pfizer Hospital NDC and Labeling Change: Morphine

Product Updates

NDC and Packaging Change for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) Multiple-dose Vial

Product Updates

NDC Updates

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/500 mL (50 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Change for Heparin Sodium in 5% Dextrose Injection 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container